Antithrombotic Clinical Trial
Official title:
Effectiveness of the Application on Individualized Antithrombotic Therapy in Chinese Patients With Coronary Artery Disease
Develop an exemplary anti-thrombotic therapy network data platform and a intelligent terminal application(APP), establish an new pattern used in long-time anti-thrombotic management based on dynamic risk evaluation, and promoted and verified by 10 thousands large sample's cohort study.
1.1.Develop and optimize antithrombotic therapy network data platform and thrombotic risk
evaluate the intelligent terminal APP, establish a new pattern based on dynamic risk
evaluation and event-triggered response, settle the conundrum in clinical practice about
antithrombotic therapy such as poor compliance, lag and unreasonable in drug adjustment.
1.2.Settle the technical problem that intelligent terminal APP code isn't compatible with
most tablet PCs and smartphones.
1.3.Impel the data platform to render and integrate with the daily medical system, enhance
its accuracy, compatibility, privacy, and quality standard.
1.4.Promote the new pattern of anti-thrombotic management by large sample's cohort study,
increase the patients' compliance, reduce the readmission rate and adverse event rate of
heart and cerebral vessels.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03000673 -
A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis
|
Phase 1/Phase 2 |